BioVie Inc (BIVI)
0.4864
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:58
BioVie Enterprise Value: 9.362M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 9.362M |
| May 03, 2024 | 9.521M |
| May 02, 2024 | 9.900M |
| May 01, 2024 | 9.625M |
| April 30, 2024 | 9.506M |
| April 29, 2024 | 9.705M |
| April 26, 2024 | 9.298M |
| April 25, 2024 | 9.462M |
| April 24, 2024 | 10.12M |
| April 23, 2024 | 9.577M |
| April 22, 2024 | 9.234M |
| April 19, 2024 | 9.366M |
| April 18, 2024 | 9.442M |
| April 17, 2024 | 8.764M |
| April 16, 2024 | 9.426M |
| April 15, 2024 | 9.613M |
| April 12, 2024 | 10.32M |
| April 11, 2024 | 9.717M |
| April 10, 2024 | 8.556M |
| April 09, 2024 | 8.513M |
| April 08, 2024 | 8.748M |
| April 05, 2024 | 9.091M |
| April 04, 2024 | 9.553M |
| April 03, 2024 | 9.773M |
| April 02, 2024 | 10.92M |
| Date | Value |
|---|---|
| April 01, 2024 | 12.32M |
| March 28, 2024 | 11.04M |
| March 27, 2024 | 11.24M |
| March 26, 2024 | 11.14M |
| March 25, 2024 | 12.54M |
| March 22, 2024 | 12.92M |
| March 21, 2024 | 12.60M |
| March 20, 2024 | 14.54M |
| March 19, 2024 | 15.06M |
| March 18, 2024 | 15.74M |
| March 15, 2024 | 18.09M |
| March 14, 2024 | 16.50M |
| March 13, 2024 | 18.21M |
| March 12, 2024 | 16.38M |
| March 11, 2024 | 17.67M |
| March 08, 2024 | 18.60M |
| March 07, 2024 | 19.68M |
| March 06, 2024 | 23.07M |
| March 05, 2024 | 25.96M |
| March 04, 2024 | 32.43M |
| March 01, 2024 | 65.32M |
| February 29, 2024 | 39.41M |
| February 28, 2024 | 39.81M |
| February 27, 2024 | 40.60M |
| February 26, 2024 | 39.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.513M
Minimum
Apr 09 2024
611.77M
Maximum
Feb 03 2021
118.91M
Average
95.40M
Median
Jan 10 2022
Enterprise Value Benchmarks
| Adial Pharmaceuticals Inc | 3.701M |
| Precision BioSciences Inc | -20.54M |
| Cardiff Oncology Inc | 87.56M |
| Jaguar Health Inc | 119.52M |
| First Wave BioPharma Inc | 2.166M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.401M |
| Total Expenses (Quarterly) | 8.781M |
| EPS Diluted (Quarterly) | -0.22 |
| Earnings Yield | -240.5% |